Sedol

550

Product Type Product Size
Injection 1’S
Product Company
Helix pharma

100mg/5ml

Category:

Description

Etoposide is a podophyllotoxin derivative used to treat testicular and small cell lung tumors.

Quick Comparison

SettingsSedol removeAvastin 400mg/16ml removeCrisvin removeCyclomide removeSoranix removeLetrasan remove
NameSedol removeAvastin 400mg/16ml removeCrisvin removeCyclomide removeSoranix removeLetrasan remove
Image
Price550137,40024044432816,7107,609
Add to cart

Description
Product Type Product Size
Injection 1'S
Product Company
Helix pharma
100mg/5ml
Product Type Product Size
Injection 1'S
Product Company
Roche Pharma
Bevacizumab 400mg/16ml
Product Type Product Size Product Company
Injection 1'S Pharmasol
Product Type Product Size Product Company
Injection 1'S Pharmedic
Product Type Product Size
Tablets 30'S
Product Company
Beacon Pharmaceuticals
Sorafenib 200mg
Product Type Product Size
Tablet 30'S
Product Company
Manufacture Deva Holding / Marketed by Searle
Letrozole 2.5mg
ContentEtoposide is a podophyllotoxin derivative used to treat testicular and small cell lung tumors. " Bevacizumab is a type of targeted cancer drug treatment. It is also known as Avastin. It is a treatment for a number of different cancer types.Vincristine is a chemotherapy drug that belongs to a group of drugs called vinca alkaloids. Vincristine works by stopping the cancer cells from separating into 2 new cells. So, it stops the growth of the cancer.Cyclophosphamide is a medication primarily used in the management and treatment of neoplasms, including multiple myeloma, sarcoma, and breast cancer.Sorafenib is used to treat late-stage kidney cancer (advanced renal cell carcinoma), liver cancer (hepatocellular carcinoma) that cannot be treated by surgery, and differentiated thyroid cancer that has come back or spread to other parts of your body. Sorafenib is an antineoplastic (cancer) agent. Letrozole is a non-steroidal type II aromatase inhibitor. It blocks the active site, and therefore the electron transfer chain of CYP19A1. This competitive inhibition prevents the conversion of androgens to estrogen. This action leads to a reduction in uterine weight and elevated leuteinizing hormon.
WeightN/AN/AN/AN/AN/AN/A
DimensionsN/AN/AN/AN/AN/AN/A
Additional information
Dose

1mg/1m, 2mg/2ml

Dose

1000mg, 500mg